Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 11:44:36 GMT 2023
by
admin
on
Sat Dec 16 11:44:36 GMT 2023
|
| Protein Type | ENZYME |
| Protein Sub Type | SERINE/THREONINE-PROTEIN KINASE |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
LC31QDE6K8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
LC31QDE6K8
Created by
admin on Sat Dec 16 11:44:36 GMT 2023 , Edited by admin on Sat Dec 16 11:44:36 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
INHIBITOR -> TARGET |
DNL151 is a selective, orally bioavailable, central nervous system–penetrant, reversible inhibitor of leucine-rich repeat kinase 2 (LRRK2)
|
||
|
|
INHIBITOR -> TARGET | |||
|
|
INHIBITOR -> TARGET |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT | CHEMICAL |
|